Found: 25
Select item for more details and to access through your institution.
Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Liver Transplantation in HIV-Seropositive Individuals.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial.
- Published in:
- Diabetes Care, 2015, v. 38, n. 4, p. 696, doi. 10.2337/dc14-1850
- By:
- Publication type:
- Article
Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin.
- Published in:
- Diabetes Care, 2014, v. 37, n. 9, p. 2435, doi. 10.2337/dc13-2546
- By:
- Publication type:
- Article
Survival of Human Immunodeficiency Virus--Infected Liver Transplant Recipients.
- Published in:
- Journal of Infectious Diseases, 2003, v. 188, n. 10, p. 1412, doi. 10.1086/379254
- By:
- Publication type:
- Article
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
- Published in:
- European Heart Journal, 2020, v. 41, n. 17, p. 1625, doi. 10.1093/eurheartj/ehz821
- By:
- Publication type:
- Article
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials.
- Published in:
- European Heart Journal, 2018, v. 39, n. 42, p. 3810, doi. 10.1093/eurheartj/ehy556
- By:
- Publication type:
- Article
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Short Sleep Duration, Obstructive Sleep Apnea, Shiftwork, and the Risk of Adverse Cardiovascular Events in Patients After an Acute Coronary Syndrome.
- Published in:
- Journal of the American Heart Association, 2017, v. 6, n. 10, p. 1, doi. 10.1161/JAHA.117.006959
- By:
- Publication type:
- Article
Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 1045, doi. 10.1111/dom.12903
- By:
- Publication type:
- Article
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
- Published in:
- European Heart Journal, 2022, v. 43, n. 48, p. 5037, doi. 10.1093/eurheartj/ehac402
- By:
- Publication type:
- Article
Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y<sub>12</sub> inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.
- Published in:
- European Heart Journal, 2016, v. 37, n. 14, p. 1133, doi. 10.1093/eurheartj/ehv531
- By:
- Publication type:
- Article
Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
- Published in:
- European Heart Journal, 2016, v. 37, n. 4, p. 400, doi. 10.1093/eurheartj/ehv482
- By:
- Publication type:
- Article
Impact of Antithrombotic Regimen on Mortality, Ischemic, and Bleeding Outcomes after Transcatheter Aortic Valve Replacement.
- Published in:
- Cardiology & Therapy, 2018, v. 7, n. 1, p. 71, doi. 10.1007/s40119-018-0111-4
- By:
- Publication type:
- Article
Interventions to Lower Low-Density Lipoprotein Cholesterol and Cardiovascular Risk-Reply.
- Published in:
- 2017
- By:
- Publication type:
- letter
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Re‐adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study‐level meta‐analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase‐4 (DPP‐4) inhibitors
- Published in:
- Clinical Cardiology, 2022, v. 45, n. 7, p. 794, doi. 10.1002/clc.23844
- By:
- Publication type:
- Article
LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial.
- Published in:
- European Journal of Preventive Cardiology, 2021, v. 28, n. 8, p. 805, doi. 10.1177/2047487320902750
- By:
- Publication type:
- Article
Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome.
- Published in:
- European Journal of Preventive Cardiology, 2018, v. 25, n. 8, p. 830, doi. 10.1177/2047487318763897
- By:
- Publication type:
- Article
Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53.
- Published in:
- Clinical Chemistry, 2019, v. 65, n. 6, p. 781, doi. 10.1373/clinchem.2018.298489
- By:
- Publication type:
- Article